During the past decade, Tokyo Metropolitan Tama Medical Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tokyo Metropolitan Tama Medical Center" #1 sponsor was "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 2 trials, followed by "Bayer" with 1 trials sponsored, "Eisai Co., Ltd." with 1 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored and "Japanese Gynecologic Oncology Group" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tokyo Metropolitan Tama Medical Center" #1 collaborator was "Tokyo Medical and Dental University" with 2 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator, "Japan Blood Products Organization" with 1 trials as a collaborator and "Korean Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Tokyo Metropolitan Tama Medical Center" are "Colorectal Cancer" (2 trials), "Atrial Arrhythmia" (1 trials), "Atrial Fibrillation Non-Rheumatic" (1 trials), "Cervical Ripening" (1 trials) and "Chronic Heart Failure" (1 trials). Many other conditions were trialed in "Tokyo Metropolitan Tama Medical Center" in a lesser frequency.

Most popular intervention types in "Tokyo Metropolitan Tama Medical Center" are "Drug" (9 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "UFT adjuvant chemotherapy" (2 trials), "Antithrombin gamma" (1 trials), "Bisoprolol" (1 trials) and "Carvedilol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tokyo Metropolitan Tama Medical Center" are 8 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Tokyo Metropolitan Tama Medical Center". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Tokyo Metropolitan Tama Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tokyo Metropolitan Tama Medical Center, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".